• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用靶向定量脂质组学技术揭示透明细胞肾细胞癌中的潜在脂质生物标志物。

Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.

机构信息

Carson International Cancer Centre, Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Centre, Shenzhen University, 1098 Xueyuan Road, Shenzhen, 518000, Guangdong, China.

Key Laboratory of Optoelectronic Devices and Systems, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, China.

出版信息

Lipids Health Dis. 2021 Nov 13;20(1):160. doi: 10.1186/s12944-021-01572-z.

DOI:10.1186/s12944-021-01572-z
PMID:34774030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8590225/
Abstract

BACKGROUND

The high drug resistance and metabolic reprogramming of clear cell renal cell carcinoma (ccRCC) are considered responsible for poor prognosis. In-depth research at multiple levels is urgently warranted to illustrate the lipid composition, distribution, and metabolic pathways of clinical ccRCC specimens.

METHODS

In this project, a leading-edge targeted quantitative lipidomic study was conducted using 10 pairs of cancerous and adjacent normal tissues obtained from ccRCC patients. Accurate lipid quantification was performed according to a linear equation calculated using internal standards. Qualitative and quantitative analyses of lipids were performed with multiple reaction monitoring analysis based on ultra-performance liquid chromatography (UPLC) and mass spectrometry (MS). Additionally, a multivariate statistical analysis was performed using data obtained on lipids.

RESULTS

A total of 28 lipid classes were identified. Among them, the most abundant were triacylglycerol (TG), diacylglycerol (DG), phosphatidylcholine (PC), and phosphatidylethanolamine (PE). Cholesteryl ester (CE) was the lipid exhibiting the most considerable difference between normal samples and tumor samples. Lipid content, chain length, and chain unsaturation of acylcarnitine (CAR), CE, and DG were found to be significantly increased. Based on screening for variable importance in projection scores ≥1, as well as fold change limits between 0.5 and 2, 160 differentially expressed lipids were identified. CE was found to be the most significantly upregulated lipid, while TG was observed to be the most significantly downregulated lipid.

CONCLUSION

Based on the absolute quantitative analysis of lipids in ccRCC specimens, it was observed that the content and change trends varied in different lipid classes. Upregulation of CAR, CE, and DG was observed, and analysis of changes in the distribution helped clarify the causes of lipid accumulation in ccRCC and possible carcinogenic molecular mechanisms. The results and methods described herein provide a comprehensive analysis of ccRCC lipid metabolism and lay a theoretical foundation for cancer treatment.

摘要

背景

透明细胞肾细胞癌(ccRCC)的高耐药性和代谢重编程被认为是导致预后不良的原因。迫切需要在多个层面进行深入研究,以阐明临床 ccRCC 标本的脂质组成、分布和代谢途径。

方法

在本项目中,对 10 对来自 ccRCC 患者的癌组织和相邻正常组织进行了前沿的靶向定量脂质组学研究。根据使用内部标准计算的线性方程进行准确的脂质定量。使用基于超高效液相色谱(UPLC)和质谱(MS)的多重反应监测分析进行脂质的定性和定量分析。此外,还使用脂质数据进行了多变量统计分析。

结果

共鉴定出 28 种脂质类别。其中,含量最丰富的是三酰甘油(TG)、二酰甘油(DG)、磷脂酰胆碱(PC)和磷脂酰乙醇胺(PE)。胆固醇酯(CE)是正常样本和肿瘤样本之间差异最显著的脂质。酰基肉碱(CAR)、CE 和 DG 的脂质含量、链长和链不饱和度均显著增加。基于筛选变量重要性投影得分≥1 以及 0.5 到 2 之间的倍数变化限制,鉴定出 160 种差异表达的脂质。CE 是上调最显著的脂质,而 TG 是下调最显著的脂质。

结论

基于 ccRCC 标本中脂质的绝对定量分析,观察到不同脂质类别中的含量和变化趋势存在差异。观察到 CAR、CE 和 DG 的上调,并分析分布变化有助于阐明 ccRCC 中脂质积累的原因和可能的致癌分子机制。本文所述的结果和方法提供了对 ccRCC 脂质代谢的全面分析,为癌症治疗奠定了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/847b89274491/12944_2021_1572_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/9b4e6a642c76/12944_2021_1572_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/feefc786497c/12944_2021_1572_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/ba6a9eee1cd3/12944_2021_1572_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/6b8f8d271fd9/12944_2021_1572_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/847b89274491/12944_2021_1572_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/9b4e6a642c76/12944_2021_1572_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/feefc786497c/12944_2021_1572_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/ba6a9eee1cd3/12944_2021_1572_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/6b8f8d271fd9/12944_2021_1572_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce19/8590225/847b89274491/12944_2021_1572_Fig5_HTML.jpg

相似文献

1
Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.采用靶向定量脂质组学技术揭示透明细胞肾细胞癌中的潜在脂质生物标志物。
Lipids Health Dis. 2021 Nov 13;20(1):160. doi: 10.1186/s12944-021-01572-z.
2
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.肾细胞癌亚型中的代谢和脂质组学重编程反映了肿瘤起源区域。
Eur Urol Focus. 2019 Jul;5(4):608-618. doi: 10.1016/j.euf.2018.01.016. Epub 2018 Feb 13.
3
Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.透明细胞肾细胞癌中溶血磷脂酰胆碱酰基转移酶1上调及伴随的磷脂改变
J Exp Clin Cancer Res. 2017 May 12;36(1):66. doi: 10.1186/s13046-017-0525-1.
4
Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的脂质组学特征和相关转录组学特征。
Sci Rep. 2016 Jun 30;6:28932. doi: 10.1038/srep28932.
5
Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.通过 ProteomeLab PF-2D 对血管生成素的蛋白质组学鉴定及其与人类肾透明细胞癌临床结局的相关性。
Int J Oncol. 2013 Jun;42(6):2078-86. doi: 10.3892/ijo.2013.1889. Epub 2013 Apr 10.
6
Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.蛋白质组学分析揭示了肾透明细胞癌患者尿液中分泌存在差异的蛋白质。
Urol Oncol. 2016 Jan;34(1):5.e11-25. doi: 10.1016/j.urolonc.2015.07.016. Epub 2015 Sep 26.
7
Lipidomic profiling of non-mineralized dental plaque and biofilm by untargeted UHPLC-QTOF-MS/MS and SWATH acquisition.采用非靶向 UHPLC-QTOF-MS/MS 和 SWATH 采集技术对非矿化牙菌斑和生物膜进行脂质组学分析。
Anal Bioanal Chem. 2020 Apr;412(10):2303-2314. doi: 10.1007/s00216-019-02364-2. Epub 2020 Jan 15.
8
Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.基于 LC-HRMS 和 PLS-DA 的人肾透明细胞癌组织和尿液代谢组学研究。
Anal Bioanal Chem. 2018 Jun;410(16):3859-3869. doi: 10.1007/s00216-018-1059-x. Epub 2018 Apr 16.
9
Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.脂质组学在评估鳞状细胞癌患者组织脂质谱中的应用。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211049903. doi: 10.1177/15330338211049903.
10
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.肾细胞癌中新型预后标志物的鉴定与验证
Dan Med J. 2017 Oct;64(10).

引用本文的文献

1
Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach.膀胱癌免疫治疗中靶向代谢重编程:一种精准医学方法。
Biomedicines. 2025 May 9;13(5):1145. doi: 10.3390/biomedicines13051145.
2
Circulating bile acid profiles characteristics and the potential predictive role in clear cell renal cell carcinoma progression.循环胆汁酸谱特征及其在透明细胞肾细胞癌进展中的潜在预测作用。
BMC Nephrol. 2025 Apr 23;26(1):206. doi: 10.1186/s12882-025-04142-y.
3
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome.

本文引用的文献

1
Bioactive Lipids and Their Derivatives in Biomedical Applications.生物活性脂质及其衍生物在生物医学应用中的研究
Biomol Ther (Seoul). 2021 Sep 1;29(5):465-482. doi: 10.4062/biomolther.2021.107.
2
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
3
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma.脂质组学与转录组学的整合揭示了肾透明细胞癌中脂质代谢和组成的重编程。
肾细胞癌肿瘤的代谢特征及其与尿液代谢组的相关性。
Metabolomics. 2025 Feb 13;21(2):26. doi: 10.1007/s11306-024-02212-0.
4
HADH suppresses clear cell renal cell carcinoma progression through reduced NRF2-dependent glutathione synthesis.羟酰基辅酶A脱氢酶通过减少NRF2依赖的谷胱甘肽合成来抑制透明细胞肾细胞癌的进展。
Transl Oncol. 2024 Nov;49:102112. doi: 10.1016/j.tranon.2024.102112. Epub 2024 Sep 2.
5
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis.PI3K/AKT/mTOR 失调与肾癌代谢途径重编程:与 VHL/HIF 轴的串扰。
Int J Mol Sci. 2023 May 7;24(9):8391. doi: 10.3390/ijms24098391.
Metabolites. 2020 Dec 13;10(12):509. doi: 10.3390/metabo10120509.
4
Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.肉毒碱棕榈酰基转移酶 1A 诱导的脂肪酸氧化抑制抑制胃癌细胞进展。
Arch Biochem Biophys. 2020 Dec 15;696:108664. doi: 10.1016/j.abb.2020.108664. Epub 2020 Nov 4.
5
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.透明细胞肾细胞癌的发生机制及致死机制。
Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3.
6
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells.36kDa 膜联蛋白 A3 同种型负向调节透明细胞肾细胞癌细胞中的脂质储存。
Am J Pathol. 2020 Nov;190(11):2317-2326. doi: 10.1016/j.ajpath.2020.08.008. Epub 2020 Aug 27.
7
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.癌症中的胆固醇代谢:机制与治疗机遇。
Nat Metab. 2020 Feb;2(2):132-141. doi: 10.1038/s42255-020-0174-0. Epub 2020 Feb 10.
8
Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells.长链脂肪酸在肿瘤微环境中的积累导致胰腺内 CD8+T 细胞功能障碍。
J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20191920.
9
Lipid in Renal Carcinoma: Queen Bee to Target?肾细胞癌中的脂质:靶向的蜂王?
Trends Cancer. 2020 Jun;6(6):448-450. doi: 10.1016/j.trecan.2020.02.017. Epub 2020 Mar 17.
10
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.糖异生酶 PCK1 将 INSIG1/2 磷酸化以进行脂肪生成。
Nature. 2020 Apr;580(7804):530-535. doi: 10.1038/s41586-020-2183-2. Epub 2020 Apr 8.